Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
about
The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activitiesProduction of lentiviral vectorsSulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian CellsConformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral ActivityA novel intranuclear RNA vector system for long-term stem cell modificationComparison of lentiviral vector titration methods.Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectorsRestriction of lentivirus in monkeysHare TRIM5α restricts divergent retroviruses and exhibits significant sequence variation from closely related lagomorpha TRIM5 genesQuantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors.Mitochondria as signaling organelles in the vascular endotheliumEvolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection.The inside out of lentiviral vectorsCyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.Gene- and cell-based therapeutics for type I diabetes mellitus.Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virusViral and non-viral vectors in gene therapy: technology development and clinical trials.Multiple restrictions of human immunodeficiency virus type 1 in feline cells.Control of viral infectivity by tripartite motif proteins.Real-time quantitative PCR for the design of lentiviral vector analytical assays.Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells.Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.Induced pluripotent reprogramming from promiscuous human stemness related factors.Gene therapy for malignant brain tumors.Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.Rhesus macaque TRIM5 alleles have divergent antiretroviral specificitiesAn active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins.Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice.Mammalian Cell Division in 3D Matrices via Quantitative Confocal Reflection Microscopy.RNAi activity of siRNAs modified with 2'-aminoalkyl-substituted fluorinated nucleobases.
P2860
Q24561930-E1E28B3C-75A8-45FF-9CE1-085591673CD2Q26750586-1EB519EC-6973-43FF-89F1-9779B98D48DEQ27478383-F8EF5A68-5F65-4215-8158-2A824911DB79Q27664241-14298E69-673F-4484-BFCE-18F228B410A2Q28603323-4D060DD4-4A20-4918-8C75-7FE8F3C83313Q33249932-E0C729F2-1EA6-4587-86F8-3498F4F58DC6Q33672711-22AAEB87-62B9-401E-9099-79A5476A1D3AQ34154725-636C24CE-AEAE-4D6D-B474-19C87E290E38Q34291026-F243E84A-211F-45FD-96AF-47CEE7CAF979Q34507124-0D0BB75E-0E08-4921-B0B0-938DD923449FQ34600173-D7AE52B2-6E5A-4929-985A-52D01B0B6EF3Q34624596-8623DACB-5218-49DE-9233-9C5B2DA73A0DQ34633466-938CF2AD-E71F-41C4-BF26-74B6EAB131A6Q35023710-AAFCD74A-00DC-4E8D-9A46-2D20AF744836Q35112900-5B6AF0CA-6EB7-4212-AB33-052C86F9B5BFQ35122170-7653A7E0-8665-41C4-8192-501765A5A7CEQ35543170-B95717D4-6363-4B3F-9F3F-E8EB5A09FD37Q35551705-C212FC0F-3FD1-40A7-93DC-6F1D950F881FQ35914370-C344370E-CC35-445B-9836-6F67E8FD9E88Q36283603-F5F61F71-F867-4CE4-9B99-E25E094A4F7FQ36288916-2F456837-1E1E-4732-B7EA-485D2D43EC48Q36315023-996D08CD-98BA-4D80-B4A9-63BC8CACD827Q36828170-7249F8CF-B853-4DC9-8871-E29183613A0AQ37217396-647CE3FB-B180-4F47-AD94-17CA16452DA0Q37349571-B5DCB742-D5ED-408B-8A85-90B6CF985541Q37610257-BA2ADE1E-52C1-430D-8BD7-8DD218D3CA64Q38338190-68644E11-9F55-4BD7-BBE3-15CC32233E1EQ38906287-F3DCEF1E-AB7B-40C0-BB26-80CCE0740CBEQ39419407-685C3482-69CA-41DF-82E4-E04499290BE6Q39616618-04C80C54-5F1D-4B45-B220-ABCD69E8539AQ39764145-6C84B0AC-110C-43A0-A894-4A185495DD05Q42111956-2B5E06F5-5223-41A7-B40F-3B0216F3B049Q44536266-EA4BB9A1-8D76-4A7D-AD34-BC64A482223EQ47212423-8807DD17-F7B9-4172-86E5-52C6DB92895FQ50654750-B65D2353-3888-46F2-BCC5-5FF747A23A0A
P2860
Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
@en
type
label
Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
@en
prefLabel
Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
@en
P2093
P2860
P356
P1433
P1476
Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
@en
P2093
Collins MK
Mitrophanous KA
Radcliffe PA
Takeuchi Y
P2860
P2888
P304
P356
10.1038/SJ.GT.3301708
P577
2002-07-01T00:00:00Z
P5875
P6179
1030974945